Skip to main content
. 2022 Aug 19;7(11):2378–2387. doi: 10.1182/bloodadvances.2022008378

Table 3.

Response outcomes

Characteristic Overall
N = 50
Arm A: AZA + ENA
n = 27
Arm B: ENA
n = 23
ORR 28 (56) [42-69] 20 (74) [53-88] 8 (35) [17-57]
CR 12 (24) [14-38] 7 (26) [12-47] 5 (22) [9-45]
mCR 9 (18) [9-32] 9 (33) [18-54]
mCR + HI 6 (12) [5-25] 3 (11) [3-31] 3 (13) [4-36]
Partial response 1 (2.0) [0-14] 1 (3.7) [1-25]
Stable disease 18 (36) [24-51] 6 (22) [10-43] 12 (52) [31-73]
Not evaluable 3 (6.0) [1-18] 1 (3.7) [1-25] 2 (8.7) [2-31]
No response 1 (2.0) [0-14] 1 (4.3) [1-28]

HI, hematologic improvement.

Values are presented as n (%) [95% CI].